“Research use only”, often shortened to RUO, appears on laboratory materials and supplier pages. It is a statement you should read alongside the actual product description and documentation. It does not replace the questions about what the material is, what was measured or whether it fits a particular research project.
Read the supplier's actual statement
Novum's stated intended use is laboratory research only, not human or veterinary use. That is the scope in which this Research Hub discusses materials. A product name or a discussion of published science should not be read as instructions to use a research reagent outside that scope.
For any supplier, record the full intended-use wording rather than relying on an abbreviation alone. “Research” can describe many different activities, and three letters do not specify the experimental model, analytical requirement or institutional process applicable to your work.
A practical reading order is to identify the material first, read the intended-use statement, and then examine the documents relevant to the proposed laboratory task. Keep these as separate fields in your notes. This prevents the intended-use label from becoming a substitute for the specification.
RUO does not describe a measurement
| Statement | Relevant information |
|---|---|
| Intended for laboratory research | The supplier's stated scope |
| Matches a named molecular identity | Identity definition and analytical evidence |
| Contains a reported amount | Assay result, units and sample basis |
| Meets a project requirement | The project's criterion and evidence addressing it |
A label cannot supply a missing assay, sterility result, impurity limit or stability record. Equally, a reported analytical result does not change the intended-use statement. If a project depends on an attribute, ask for the evidence for that attribute rather than inferring it from RUO.
It is not a regulatory shortcut
UK MHRA guidance explains that classification as a medicinal product considers factors including claims, properties, intended purpose and overall presentation. The assessment is therefore broader than one phrase printed on a label. This guidance does not provide a regulatory determination for any particular Novum product.MHRA classification guidance (opens in a new tab)
Do not rewrite RUO as “MHRA approved”, “exempt from regulation” or “approved for experimental treatment”. Those are different claims. A question about the legal status of a particular product needs the relevant product-specific assessment; the abbreviation does not settle it.
The same distinction helps when reading overseas websites. A label used in one jurisdiction or product category should not be assumed to establish the status of a different product in the UK. Preserve the context of the original statement rather than borrowing its apparent authority.
What establishes suitability for a research task?
Begin with what the task actually requires. An identity comparison, a quantitative analytical experiment and a biological assay can need different information. State the relevant material definition, measurements and documentation before deciding whether the available evidence is enough.
For example, a study intended to compare two named sequences needs confidence that the material definitions are correct. A study comparing amounts needs an appropriate quantitative basis. Neither requirement is satisfied just because both bottles carry the same intended-use wording.
- Define the laboratory question before choosing the material.
- Identify the attributes that could affect the interpretation.
- Check the available documents against those attributes.
- Record unresolved requirements as unresolved, not as implied by the label.
Use wording that preserves the boundary
A careful description says what the supplier states and what the documents support. It does not turn research-use language into a recommendation for personal use, an approval claim or a guarantee that a material fits every experiment. Keeping these categories separate makes the record clearer for the next reader.
Sources and further detail
- MHRA — Borderline products: how to tell if your product is a medicine (opens in a new tab)
UK guidance, updated 2 July 2026 when accessed. Used for the factors in classification, not a product-specific legal conclusion.
Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.